Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acepodia, Ascletis, Aslan, Biontech, Cynata, Novavax, Organicell Regenerative Medicine, Pfizer, Reithera, Revive, Sab, Telix Pharmaceuticals Japan, Trevena, Vanda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Arcturus, Ascletis, Blade, Botanix, GNI Group, I-Mab, Merck, Novavax, Romark Laboratories, SAB, Syndax.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Angion Biomedica, Arch Biopartners, Bioaegis, Biontech, Cstone, Cytodyn, Eli Lilly, Enlivex, Everest Medicines, Humanigen, Idorsia, Innovent Biologics, Kamada, Ligand, Novavax, Oncolys, Pharming, Shanghai Fosun, Tessa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AI, Ampio, Ascentage, Cerecor, Clarity, Cytodyn, Hutchison China Meditech, Immunic, Moderna, Opthea.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AI, Ampio, Ascentage, Cerecor, Clarity, Cytodyn, Hutchison China Meditech, Immunic, Moderna, Opthea.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akebia, Algernon, Ascletis, Astrazeneca, Bioarctic, Biogen, Biontech, Calcimedica, Celltrion, China National, Dynavax, Eisai, Glaxosmithkline, Heron, Medicago, Moderna, Neurorx, Pfizer, Phasebio, Relief, Ribomic, Rigel, Santen, Synairgen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Angion, Bellerophon, Biosig, Center Laboratories, Chugai, Constant, Corvus, Evive, Gilead Sciences, Innovent Biologics, JS Innopharm, Junshi, Moderna, Novartis, Ridgeback, Sosei, Viralclear.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 4D Pharma, Abivax, Biontech, CSL Behring, Daiichi Sankyo, Depuy Synthes Products, Durect, Inovio, Oncolys, Orthocell, Pfizer, Regeneron, Sanofi, Timber, Transcenta.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Fibrogen, Immutep, Montreal Heart Institute, Noxopharm, Revimmune.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acadia, Aribio, Ascentage, Ascletis, Biosig Technologies, Clover, Eli Lilly, Evelo, Evgen, FSD, Hua Medicine, Humanigen, Inflarx, Innovent, Kiniksa, Neuren, Remegen, Ridgeback, Sagimet.